Andrew D. Norden

8.4k total citations
122 papers, 4.9k citations indexed

About

Andrew D. Norden is a scholar working on Genetics, Molecular Biology and Cancer Research. According to data from OpenAlex, Andrew D. Norden has authored 122 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Genetics, 39 papers in Molecular Biology and 24 papers in Cancer Research. Recurrent topics in Andrew D. Norden's work include Glioma Diagnosis and Treatment (69 papers), Cancer, Hypoxia, and Metabolism (19 papers) and Brain Metastases and Treatment (17 papers). Andrew D. Norden is often cited by papers focused on Glioma Diagnosis and Treatment (69 papers), Cancer, Hypoxia, and Metabolism (19 papers) and Brain Metastases and Treatment (17 papers). Andrew D. Norden collaborates with scholars based in United States, Netherlands and United Kingdom. Andrew D. Norden's co-authors include Patrick Y. Wen, Jan Drappatz, Hal Blumenfeld, Santosh Kesari, E. C. Quant, Lakshmi Nayak, Debra C. LaFrankie, Rameen Beroukhim, Eudocia Q. Lee and David A. Reardon and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Andrew D. Norden

119 papers receiving 4.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew D. Norden United States 39 2.2k 1.2k 1.1k 1.1k 838 122 4.9k
Christian Senft Germany 36 2.3k 1.0× 1.3k 1.1× 762 0.7× 979 0.9× 747 0.9× 171 4.8k
Jan Drappatz United States 42 3.0k 1.3× 934 0.8× 1.6k 1.4× 1.1k 1.1× 1.2k 1.4× 155 5.3k
Brian V. Nahed United States 35 1.3k 0.6× 777 0.6× 1.3k 1.2× 1.2k 1.2× 1.1k 1.3× 176 5.5k
Steven N. Kalkanis United States 39 2.6k 1.2× 1.3k 1.0× 1.1k 1.0× 675 0.6× 2.3k 2.7× 132 5.5k
François Ducray France 38 3.5k 1.5× 989 0.8× 1.7k 1.5× 2.1k 2.0× 1.3k 1.5× 206 6.3k
John L. Villano United States 34 2.6k 1.2× 869 0.7× 1.1k 1.0× 1.1k 1.0× 1.2k 1.5× 141 5.0k
Tina Young Poussaint United States 43 2.2k 1.0× 585 0.5× 900 0.8× 1.6k 1.5× 667 0.8× 148 4.6k
Ghazaleh Tabatabai Germany 38 2.7k 1.2× 1.1k 0.9× 1.9k 1.7× 724 0.7× 926 1.1× 183 5.3k
Michael R. Chicoine United States 43 1.2k 0.5× 1.5k 1.3× 698 0.6× 1.9k 1.8× 967 1.2× 159 4.9k
Xiaobu Ye United States 39 2.3k 1.0× 946 0.8× 1.3k 1.2× 644 0.6× 1.4k 1.7× 151 6.8k

Countries citing papers authored by Andrew D. Norden

Since Specialization
Citations

This map shows the geographic impact of Andrew D. Norden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew D. Norden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew D. Norden more than expected).

Fields of papers citing papers by Andrew D. Norden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew D. Norden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew D. Norden. The network helps show where Andrew D. Norden may publish in the future.

Co-authorship network of co-authors of Andrew D. Norden

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew D. Norden. A scholar is included among the top collaborators of Andrew D. Norden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew D. Norden. Andrew D. Norden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lamont, Elizabeth B., Andrew J. Yee, Stuart L. Goldberg, David S. Siegel, & Andrew D. Norden. (2020). Associations Between Amplification (1q) and Prior Cancer in a Real-World De Novo Myeloma Cohort. JNCI Cancer Spectrum. 5(1). 1 indexed citations
2.
Gutierrez, Martin, Agnieszka Woźniak, Corey J. Langer, et al.. (2018). P2.01-42 Impact of Tobacco Smoking on Outcomes in Patients with Metastatic Non-Small Cell Lung Cancer in the Era of Targeted Therapy. Journal of Thoracic Oncology. 13(10). S680–S681. 1 indexed citations
3.
4.
Lee, Eudocia Q., Dan G. Duda, Alona Muzikansky, et al.. (2018). Phase I and Biomarker Study of Plerixafor and Bevacizumab in Recurrent High-Grade Glioma. Clinical Cancer Research. 24(19). 4643–4649. 49 indexed citations
5.
Biran, Noa, Andrew D. Norden, David H. Vesole, et al.. (2018). Multiple Myeloma Staging in Real World Clinical Practice Is Suboptimal: Absence of Beta-2-Microglobulin and Serum Lactase Dehydrogenase Testing Are Limiting Factors. Blood. 132(Supplement 1). 5587–5587. 1 indexed citations
6.
Lee, Jong Woo, Andrew D. Norden, Keith L. Ligon, et al.. (2014). Tumor associated seizures in glioblastomas are influenced by survival gene expression in a region-specific manner: A gene expression imaging study. Epilepsy Research. 108(5). 843–852. 16 indexed citations
7.
Smith, Katrina H., Eudocia Q. Lee, Alona Muzikansky, et al.. (2014). Phase I study of plerixafor and bevacizumab in recurrent high-grade glioma.. Journal of Clinical Oncology. 32(15_suppl). 2031–2031. 1 indexed citations
8.
Norden, Andrew D., David Schiff, Manmeet S. Ahluwalia, et al.. (2014). Phase II trial of triple tyrosine kinase receptor inhibitor nintedanib in recurrent high-grade gliomas: Final results.. Journal of Clinical Oncology. 32(15_suppl). 2053–2053. 1 indexed citations
9.
Kaley, Thomas, Patrick Y. Wen, David Schiff, et al.. (2014). Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma. Neuro-Oncology. 17(1). 116–121. 194 indexed citations
10.
Craig, Justin M., Natalie Vena, Shakti Ramkissoon, et al.. (2012). DNA Fragmentation Simulation Method (FSM) and Fragment Size Matching Improve aCGH Performance of FFPE Tissues. PLoS ONE. 7(6). e38881–e38881. 20 indexed citations
11.
Quant, E. C., Tracy T. Batchelor, Andrew B. Lassman, et al.. (2011). Preliminary results from a multicenter, phase II, randomized, noncomparative clinical trial of radiation and temozolomide with or without vandetanib in newly diagnosed glioblastoma (GBM).. Journal of Clinical Oncology. 29(15_suppl). 2069–2069. 8 indexed citations
12.
Drappatz, Jan, Jeffrey J. Raizer, David Schiff, et al.. (2011). A phase I trial of LBH589 and bevacizumab for recurrent high-grade glioma (HGG).. Journal of Clinical Oncology. 29(15_suppl). 2050–2050. 6 indexed citations
13.
Reardon, David A., Andrew D. Norden, Annick Desjardins, et al.. (2011). Phase II study of Gleevec® plus hydroxyurea (HU) in adults with progressive or recurrent meningioma. Journal of Neuro-Oncology. 106(2). 409–415. 63 indexed citations
14.
Norden, Andrew D., Jan Drappatz, Patrick Y. Wen, & Elizabeth B. Claus. (2010). Survival among patients with primary central nervous system lymphoma, 1973–2004. Journal of Neuro-Oncology. 101(3). 487–493. 60 indexed citations
15.
Lu‐Emerson, Christine, Andrew D. Norden, Jan Drappatz, et al.. (2010). Retrospective study of dasatinib for recurrent glioblastoma after bevacizumab failure. Journal of Neuro-Oncology. 104(1). 287–291. 54 indexed citations
16.
Norden, Andrew D., Jan Drappatz, & Patrick Y. Wen. (2009). Antiangiogenic therapies for high-grade glioma. Nature Reviews Neurology. 5(11). 610–620. 197 indexed citations
17.
Norden, Andrew D., Jan Drappatz, A. S. Ciampa, et al.. (2008). Colon perforation during antiangiogenic therapy for malignant glioma. Neuro-Oncology. 11(1). 92–95. 16 indexed citations
18.
Chi, Andrew, Andrew D. Norden, & Patrick Y. Wen. (2007). Inhibition of angiogenesis and invasion in malignant gliomas. Expert Review of Anticancer Therapy. 7(11). 1537–1560. 44 indexed citations
19.
Norden, Andrew D. & Patrick Y. Wen. (2006). Glioma Therapy in Adults. The Neurologist. 12(6). 279–292. 104 indexed citations
20.
Blumenfeld, Hal, Kelly McNally, A. LeBron Paige, et al.. (2004). Positive and Negative Network Correlations in Temporal Lobe Epilepsy. Cerebral Cortex. 14(8). 892–902. 253 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christian Senft Breakdown of academic impact, for papers by Jan Drappatz Breakdown of academic impact, for papers by Brian V. Nahed Breakdown of academic impact, for papers by Steven N. Kalkanis Breakdown of academic impact, for papers by François Ducray Breakdown of academic impact, for papers by John L. Villano Breakdown of academic impact, for papers by Tina Young Poussaint Breakdown of academic impact, for papers by Ghazaleh Tabatabai Breakdown of academic impact, for papers by Michael R. Chicoine Breakdown of academic impact, for papers by Xiaobu Ye
Rankless by CCL
2026